drugset / Trial / NCT02055365

Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

NCT02055365

Completed 10 enrolled Rockefeller University
NaSingle-groupOpen-labelBasic science

Summary

Vaccines have been responsible for preventing millions of deaths and extending the average human lifespan. Effective vaccines stimulate the cells of the immune system to activate genes and associated functions that bring about protective immunity.This study aims to define cellular functions and genes important for the hepatitis B (HBV) vaccine immune response in healthy individuals. The investigators hypothesize that many genes associated with innate and adaptive immune functions are important for an effective HBV vaccine response.

Timeline

Start
2014-02-18
Primary completion
2015-01-06
Completion
2015-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject HEPLISAV-B Vaccine